164 related articles for article (PubMed ID: 35227956)
1. Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19.
Tripon S; Bilbault P; Fabacher T; Lefebvre N; Lescuyer S; Andres E; Schmitt E; Garnier-KepKA S; Borgne PL; Muller J; Merdji H; Chaffraix F; Mutter D; Baumert TF; Meziani F; Doffoel M
Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101894. PubMed ID: 35227956
[TBL] [Abstract][Full Text] [Related]
2. COVID-19: Abnormal liver function tests.
Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
[TBL] [Abstract][Full Text] [Related]
4. A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests.
Gan Q; Gong B; Sun M; Cao Z; Zheng Y; Zhang Y; Wen P; Shen Y; Hong L; Hou T; Jia Y; Li W; Li H; Xie Q
Front Physiol; 2021; 12():642922. PubMed ID: 33815147
[TBL] [Abstract][Full Text] [Related]
5. Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
Elfeki MA; Robles J; Akhtar Z; Ullah F; Ganapathiraju I; Tran C; Inman C; Collin SM; Rosa R
Dig Dis Sci; 2022 Jul; 67(7):3333-3339. PubMed ID: 34173917
[TBL] [Abstract][Full Text] [Related]
6. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19).
Lopez-Mendez I; Aquino-Matus J; Gall SM; Prieto-Nava JD; Juarez-Hernandez E; Uribe M; Castro-Narro G
Ann Hepatol; 2021; 20():100271. PubMed ID: 33099028
[TBL] [Abstract][Full Text] [Related]
7. Effects of COVID-19 on the liver: The experience of a single center.
Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
[TBL] [Abstract][Full Text] [Related]
8. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
[TBL] [Abstract][Full Text] [Related]
10. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.
Li MR; Li JZ; Li JY; Wang CC; Yuan RK; Ye LH; Liu YY; Liang XJ; Zhang HC; Liu ZQ; Zeng DY; Zhang XD; Wang DH; Li JQ; Li TY; Yang L; Cao Y; Pan Y; Lin XG; Pan CQ; Dai EH; Dong ZY
Obes Facts; 2023; 16(5):427-434. PubMed ID: 37231905
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
[TBL] [Abstract][Full Text] [Related]
13. Effect of Nonalcoholic Fatty Liver Disease (NAFLD) on COVID-19: A Single-Center Study of 3983 Patients With Review of Literature.
Nath P; Kumar R; Mallick B; Das S; Anand A; Panigrahi SC; Duseja A; Acharya SK; Chawla YK; Praharaj DL
Cureus; 2022 Jul; 14(7):e26683. PubMed ID: 35949776
[TBL] [Abstract][Full Text] [Related]
14. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
[TBL] [Abstract][Full Text] [Related]
15. Repeated measurements of non-invasive fibrosis tests to monitor the progression of non-alcoholic fatty liver disease: A long-term follow-up study.
Balkhed W; Åberg FO; Nasr P; Ekstedt M; Kechagias S
Liver Int; 2022 Jul; 42(7):1545-1556. PubMed ID: 35319156
[TBL] [Abstract][Full Text] [Related]
16. Comparison of liver function test- and inflammation-based prognostic scores for coronavirus disease 2019: a single center study.
Cholongitas E; Bali T; Georgakopoulou VE; Kamiliou A; Vergos I; Makrodimitri S; Samara S; Triantafylou M; Basoulis D; Eliadi I; Karamanakos G; Sipsas NV; Samarkos M
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1165-1171. PubMed ID: 36170686
[TBL] [Abstract][Full Text] [Related]
17. Effect of COVID-19 on patients with compensated chronic liver diseases.
Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
[TBL] [Abstract][Full Text] [Related]
18. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
[TBL] [Abstract][Full Text] [Related]
19. Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores.
Yao R; Zhu L; Wang J; Liu J; Xue R; Xue L; Liu L; Li C; Zhao H; Cheng J; Huang S; Li Y; Zhao XA; Zhu C; Li M; Huang R; Wu C
J Clin Lab Anal; 2021 Aug; 35(8):e23880. PubMed ID: 34213039
[TBL] [Abstract][Full Text] [Related]
20. In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.
Forlano R; Mullish BH; Mukherjee SK; Nathwani R; Harlow C; Crook P; Judge R; Soubieres A; Middleton P; Daunt A; Perez-Guzman P; Selvapatt N; Lemoine M; Dhar A; Thursz MR; Nayagam S; Manousou P
PLoS One; 2020; 15(10):e0240400. PubMed ID: 33031439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
